Viridian Therapeutics News

Viridian Therapeutics | 10-Q: Quarterly report

May 8 07:53 ET

Viridian Therapeutics | 8-K: Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results

May 8 07:13 ET

Viridian Therapeutics | ARS: Annual Report to Security Holders

Apr 26 08:38 ET

Viridian Therapeutics | DEFA14A: Others

Apr 26 08:38 ET

Viridian Therapeutics | DEF 14A: Definitive information statements

Apr 26 08:33 ET

Viridian Therapeutics | 8-K: Current report

Apr 16 16:11 ET

Viridian Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(18.64%),Fairmount Healthcare Fund II GP LLC(18.64%), etc.

Apr 1 18:43 ET

Viridian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC

Apr 1 18:38 ET

Viridian Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 28 22:45 ET

Viridian Therapeutics | 10-K: Annual report

Feb 27 16:42 ET

Viridian Therapeutics | 8-K: Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 27 16:17 ET

Viridian Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(9.99%),VHCP Co-Investment Holdings III, LLC(9.99%), etc.

Feb 14 20:33 ET

Viridian Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Tousignant Jennifer

Feb 14 18:06 ET

Viridian Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(3.7%),Commodore Capital Master LP(3.7%)

Feb 14 18:05 ET

Viridian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Tousignant Jennifer

Feb 14 18:05 ET

Viridian Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Feb 14 17:53 ET

Viridian Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%), etc.

Feb 14 09:27 ET

Viridian Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(9.90%),Deep Track Biotechnology Master Fund, Ltd.(9.90%), etc.

Feb 14 09:02 ET

Viridian Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.71%)

Feb 13 22:30 ET

Viridian Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ciulla Thomas

Feb 7 16:02 ET